Search research articles
Contact Us
Filters
Showing results (11-20 of 193) with videos related to
Page
of 20
Sort By:
Lancet (London, England)
|
May 5, 1990
False positives with current carbocisteine protocol for sulphoxidation phenotyping
A Küpfer, J R Idle
IARC Scientific Publications
|
January 1, 1982
Population studies of polymorphism in drug oxidation and its relevance to carcinogenesis
J C Ritchie, J R Idle
Pharmacogenetics
|
December 1, 1995
Pharmacogenetics in the new patterns of healthcare delivery
J R Idle, R L Smith
Journal of Chromatography
|
March 13, 1992
Combined thin-layer chromatography-photography-densitometry for the quantification of ifosfamide and its principal metabolites in urine, cerebrospinal fluid and plasma
A V Boddy, J R Idle
Environmental Health Perspectives
|
October 1, 1993
New opportunities in cancer risk evaluation using PCR-based DNA analysis for CYP2D6
J R Idle, A K Daly
Cancer Surveys
|
January 1, 1993
The role of pharmacogenetics in chemotherapy: modulation of tumour response and host toxicity
A V Boddy, J R Idle
Drug Metabolism Reviews
|
January 1, 1979
Polymorphisms of oxidation at carbon centers of drugs and their clinical significance
J R Idle, R L Smith
Clinical Pharmacokinetics
|
January 1, 1994
Pharmacogenetic phenotyping and genotyping. Present status and future potential
F J Gonzalez, J R Idle
Comparative Biochemistry and Physiology. C: Comparative Pharmacology
|
January 1, 1977
The conjugation of benzoic acid and phenylacetic acid by the Pipistrelle bat
M M Angelo, J R Idle
Journal of Chromatography
|
May 13, 1988
Combined thin-layer chromatography-photography-densitometry for the quantitation of cyclophosphamide and its four principal urinary metabolites
A H Hadidi, J R Idle
Page
of 20
Search research articles
Search
Showing results (11-20 of 193) with videos related to
Sort By:
Page
of 20
Lancet (London, England)
|
May 5, 1990
False positives with current carbocisteine protocol for sulphoxidation phenotyping
A Küpfer, J R Idle
IARC Scientific Publications
|
January 1, 1982
Population studies of polymorphism in drug oxidation and its relevance to carcinogenesis
J C Ritchie, J R Idle
Pharmacogenetics
|
December 1, 1995
Pharmacogenetics in the new patterns of healthcare delivery
J R Idle, R L Smith
Journal of Chromatography
|
March 13, 1992
Combined thin-layer chromatography-photography-densitometry for the quantification of ifosfamide and its principal metabolites in urine, cerebrospinal fluid and plasma
A V Boddy, J R Idle
Environmental Health Perspectives
|
October 1, 1993
New opportunities in cancer risk evaluation using PCR-based DNA analysis for CYP2D6
J R Idle, A K Daly
Cancer Surveys
|
January 1, 1993
The role of pharmacogenetics in chemotherapy: modulation of tumour response and host toxicity
A V Boddy, J R Idle
Drug Metabolism Reviews
|
January 1, 1979
Polymorphisms of oxidation at carbon centers of drugs and their clinical significance
J R Idle, R L Smith
Clinical Pharmacokinetics
|
January 1, 1994
Pharmacogenetic phenotyping and genotyping. Present status and future potential
F J Gonzalez, J R Idle
Comparative Biochemistry and Physiology. C: Comparative Pharmacology
|
January 1, 1977
The conjugation of benzoic acid and phenylacetic acid by the Pipistrelle bat
M M Angelo, J R Idle
Journal of Chromatography
|
May 13, 1988
Combined thin-layer chromatography-photography-densitometry for the quantitation of cyclophosphamide and its four principal urinary metabolites
A H Hadidi, J R Idle
Page
of 20